Oxford Investment Consultants (trading as OTIF Ventures) is a venture capital firm based in Oxford, UK, backing early-stage, EIS-eligible spinout companies from world-leading UK universities, with a focus on Oxford and Cambridge. The firm invests across life sciences, deep tech, and physical sciences, backing founders turning scientific research into commercial products.
40% of their portfolio is in Healthcare. Their most common stage is series-a (70% of deals). Average disclosed round size is $20.1M (across 4 rounds with reported amounts).
Portfolio
8
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Oxford Endovascular | Series A | — | May 2024 |
 Navenio | Series A | — | Sep 2023 |
 Brill Power | Seed | — | Jul 2022 |
 Brill | Series A | $10.5M | Jul 2022 |
 Oxford Quantum Circuits | Series A | $47M | Jul 2022 |
| Brill Power | Series A | $10.5M | Jan 2022 |
 Living Optics | Series A | — | Jan 2022 |
 Orthoson | Seed | — | Nov 2019 |
| OOxford Quantum Circuits Limited | Series A | — | — |
| Navenio | Growth | $12.6M | — |
Top Co-Investors
Oxford Science Enterprises8 shared
Shell Ventures3 shared
Legal & General3 shared
Oxford University3 shared
Lansdowne Partners2 shared
UTEC2 shared
British Patient Capital2 shared
Future Planet Capital2 shared
Big Pi Ventures2 shared
Barclays2 shared
British Business Bank1 shared
Hostplus1 shared
G. K. Goh Ventures1 shared
IP Group plc1 shared
Barclays Sustainable Impact Capital1 shared
Oxford Sciences Innovation1 shared
Perivoli Innovations1 shared
Parkwalk Advisors1 shared
Starting Line1 shared
Octopus Ventures1 shared
Last updated: 9 September 2026